Aug 23 (Reuters) - Seqirus:
* SEQIRUS SECURES FDA APPROVAL FOR NEXT GENERATION CELL-BASED INFLUENZA VACCINE MANUFACTURING PROCESS
* SEQIRUS - APPROVAL WILL ENABLE CO TO MORE THAN DOUBLE CURRENT PRODUCTION LEVELS OF FLUCELVAX QUADRIVALENT FOR SUPPLY IN 2019/20 INFLUENZA SEASON